Cargando…
Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways
BACKGROUND/PURPOSE: Pristimerin (Pris) is triterpenoid compound with many biological effects. Until now, nothing is known about its effect on doxorubicin (DOX)-induced cardiotoxicity. Hence, this study investigated the impact of Pris on DOX-induced cardiotoxic effects. MATERIALS AND METHODS: Rats we...
Autores principales: | El-Agamy, Dina S, El-Harbi, Khaled M, Khoshhal, Saad, Ahmed, Nishat, Elkablawy, Mohamed A, Shaaban, Ahmed A, Abo-Haded, Hany M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304079/ https://www.ncbi.nlm.nih.gov/pubmed/30588110 http://dx.doi.org/10.2147/CMAR.S186696 |
Ejemplares similares
-
Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis
por: El-Agamy, Dina S., et al.
Publicado: (2018) -
Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity
por: Abo-Haded, Hany M., et al.
Publicado: (2017) -
Assessment of quality of life among parents of children with congenital heart disease using WHOQOL-BREF: a cross-sectional study from Northwest Saudi Arabia
por: Khoshhal, Saad, et al.
Publicado: (2019) -
Alpha-Mangostin as a New Therapeutic Candidate for Concanavalin A-Induced Autoimmune Hepatitis: Impact on the SIRT1/Nrf2 and NF-κB Crosstalk
por: Shehata, Ahmed M., et al.
Publicado: (2022) -
Cytokine Profiling among Children with Multisystem Inflammatory Syndrome versus Simple COVID-19 Infection: A Study from Northwest Saudi Arabia
por: Abo-Haded, Hany M., et al.
Publicado: (2022)